Advances in molecular oncology icon

0.2.2 by Your Digital Publishing, LLC


May 12, 2016

About Advances in molecular oncology

English

Scientific and practical reviewed journal

"ABV-press" publishing house

Scientific and practical reviewed journal

"Advances in molecular oncology" - is a quarterly peer-reviewed journal of research and practice. It was founded in 2014.

Editor-in-chief - The head of laboratory of molecular endocrinology of N.N. Blokhin Russian Cancer Research Center Krasilnikov Mikhail Alexandrovich, PhD, DSc, Professor.

Target audience: oncologists, molecular biologists, geneticists, biochemists, virologists, cancer epidemiologists, chemotherapists.

Information content: reviews, mini-reviews, brief communications and full-size research articles, comments of leading experts. Editorial board members and authors of the journal are the leading Russian and foreign oncologists, molecular biologists, geneticists, chemotherapists and specialists of related professions.

Frequency: 4 issues per year

Format: A4.

Page contents: from 72 to100 pages.

Circulation: 1000 copies.

Distribution: address in the Russian Federation and CIS countries.

Index of subscription: "Press of Russia" catalogue – 93562

ISSN: 2313-805X (Print)

ISSN: 2413-3787 (Online)

What's New in the Latest Version 0.2.2

Last updated on May 12, 2016

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Advances in molecular oncology Update 0.2.2

Requires Android

2.3.3 and up

Show More

Advances in molecular oncology Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.